XML 81 R66.htm IDEA: XBRL DOCUMENT v3.22.4
Earnings Per Share - Summary (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Numerator:      
Net loss attributable to Surgery Partners, Inc. $ (54.6) $ (70.9) $ (116.1)
Less: amounts allocated to participating securities 0.0 (10.3) (39.5)
Net loss attributable to common stockholders (54.6) (81.2) (155.6)
Net loss attributable to common stockholders (diluted) $ (54.6) $ (81.2) $ (155.6)
Denominator:      
Weighted average shares outstanding - basic (shares) [1] 91,952 72,427 48,776
Weighted average shares outstanding - diluted (shares) [1] 91,952 72,427 48,776
Basic (in USD per share) [1] $ (0.59) $ (1.12) $ (3.19)
Diluted (in USD per share) [1] $ (0.59) $ (1.12) $ (3.19)
Stock options      
Denominator:      
Dilutive securities outstanding not included in the computation of diluted loss per share as their effect is antidilutive (shares) 1,459 1,920 712
Restricted shares      
Denominator:      
Dilutive securities outstanding not included in the computation of diluted loss per share as their effect is antidilutive (shares) 679 1,452 981
[1] The impact of potentially dilutive securities for all periods were not considered because the effect would be anti-dilutive in those periods.